JUN 27, 2017 7:37 PM PDT

Relieving "Exhausted" Immune Cells To Kill Cancer

WRITTEN BY: Kara Marker

How do T cells become so “exhausted” that they can no longer effectively fight cancer, viruses, bacteria, and other invaders as they are created to do? Scientists from St. Jude Children’s Research Hospital have an answer as well as a way to overcome this exhaustion.

Corresponding author Benjamin Youngblood, PhD with first author Hazem Ghoneim. Credit: Seth Dixon / St. Jude Children's Research Hospital

T cells are key players of the immune system that protect the body from an array of attacks, but when they can’t recognize foreign cells, they can’t direct the immune system to attack. With St. Jude scientists already in the process of designing techniques to rejuvenate T cells, they over the possibility of improving existing immunotherapies to reduce tumor growth, an anti-cancer strategy that relies on boosting the power of the immune system to defend itself.

When immunotherapy doesn’t reach its full potential due to T cell exhaustion, cancer often fails to respond to the treatment, or a patient quickly experiences a relapse of the disease. Researchers believe this failure is due to dysfunction of a process called the “immune checkpoint blockade.”

"The clinical significance of T cell exhaustion is huge, because when a person comes into the clinic with a tumor, it is likely they have had it for many months," explained lead researcher Ben Youngblood, PhD.. "And their T cells, which would be responding to that tumor, have been exposed to the tumor antigen for a long time. This may likely be why immunotherapy fails in many patients, because their T cells are already exhausted or stably repressed."

Youngblood’s proposed solution is based off of preclinical studies of viral infections and growing tumors, indicating a chemotherapy drug called decitabine as capable of bringing exhausted T cells back to life. Plus, the drug is claimed to have the potential to be useful against multiple types of afflictions: HIV in addition to cancer and other pathogens.

"We know the T cells in patients with HIV become exhausted," Youngblood said. "Although there are very effective drugs that reduce the viral load to undetectable levels, that therapy is costly and is not a cure. I'm optimistic that the immune system holds the ultimate promise of a cure for HIV infection, and basic findings such as ours represent one step toward that cure."

But what causes the immune checkpoint to fail leading to T cell exhaustion in the first place? Researchers found that it is an “epigenetic program” that prevented T cells from recognizing tumor cells as abnormal and requiring destruction. The epigenetic program persisted by being passed on through T cell generations. The chemotherapy drug decitabine blocks the epigenetic program preventing T cells from protecting the body from cancer.

"Now that we have shown this is an intrinsic property of T cells, it means you can pull out the T cells, treat them, and reintroduce them to attack the cancer," Youngblood explained. "With such approaches, you limit toxicity to the patient."

The present study was published in the journal Cell.

Source: St. Jude Children’s Research Hospital

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 26, 2021
Immunology
Can we Stop Multiple Sclerosis Progression?!
JAN 26, 2021
Can we Stop Multiple Sclerosis Progression?!
Multiple sclerosis is known for its progression of symptoms even after a period of complete remission. There is no way o ...
JAN 28, 2021
Neuroscience
Immune Cells Destroy Synapses in Multiple Sclerosis
JAN 28, 2021
Immune Cells Destroy Synapses in Multiple Sclerosis
Researchers from Germany have found that Multiple sclerosis (MS)-associated inflammation in the cerebral cortex destroys ...
MAR 07, 2021
Genetics & Genomics
Tuberculosis Influenced the Human Genome
MAR 07, 2021
Tuberculosis Influenced the Human Genome
Throughout human history, our species has come into contact with both harmless and infectious microbes that have changed ...
APR 15, 2021
Immunology
COVID Vaccines Protect Breastfeeding Babies Too
APR 15, 2021
COVID Vaccines Protect Breastfeeding Babies Too
Good news for families of newborns: A new study shows that breastfeeding mothers who receive a COVID vaccine share prote ...
MAY 13, 2021
Immunology
Tumors Hide From the Immune System by Masquerading as Baby Cells
MAY 13, 2021
Tumors Hide From the Immune System by Masquerading as Baby Cells
The immune system is programmed to recognize foreign bodies as potentially dangerous, promptly removing them before the ...
JUN 03, 2021
Immunology
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
JUN 03, 2021
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
Nanobodies are small fragments of monoclonal antibodies that from a therapeutic perspective are more stable and cheaper ...
Loading Comments...